Forensic Analysis · Trading Companies & Distributors · as of Aug 12, 2026

Nu Skin Enterprises, Inc. (NUS)

A forensic read on Nu Skin Enterprises, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective

Forensic grade

Safe

Financial health

6.4

Distress distance

Clean

Earnings quality

Forensic signals

4.8

P / E (ttm)

19.9%

ROE

$256M

Market cap

4.62%

Dividend yield

-14.3%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Nu Skin Enterprises, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 6.4, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

5.8%

FY2025

Return on invested capital. Return on invested capital is 5.8% in the latest fiscal year and slipping from 8% — well below its ~8% cost of capital, so reinvested dollars may be destroying value, not building it.

-0.1%/yr

FY2022–FY2025

Share count. Diluted share count changed -0% over the last 3 years to FY2025 (-0.1%/yr). Roughly flat — buybacks ($20M) are about offsetting stock comp ($24M), not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.

-85%

FY2023→FY2024

Dividend — cut. The payout was CUT ~85% in FY2024 (from FY2023). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies.

Key fundamentals

Latest Revenue$1.49B

Revenue Growth YoY-14.3%

Revenue CAGR (3yr)-12.6%

Net Margin10.8%

Free Cash Flow$46.0M

Return on Equity19.9%

Debt / Equity0.28x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Nu Skin Enterprises, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 12, 2026. Forensic signals flag probability, not certainty.